|
Status |
Public on Oct 02, 2023 |
Title |
FBP1 overexpression in MDA-MB-231 breast cancer cells |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Fructose 1,6 bisphosphatase the key enzyme of gluconeogenesis has emerged as a potential metabolic tumor suppressor. In breast cancer distinct FBP1 expression levels are found depending on subtype. In MDA-MB-231 FBP1 expression is suppressed. To get more insight into potential functions of FBP1 we introduced a vector to reintroduce expression of FBP1. These experiments are part of a more comprehensive study on expression of FBP1 in breast cancer cells.
|
|
|
Overall design |
Transfection of MDA-MB231 cells with FBP1 expression vector and empty vector for control.
|
|
|
Contributor(s) |
Wölfl S, Ghanem A |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
Submission date |
Sep 28, 2023 |
Last update date |
Oct 02, 2023 |
Contact name |
Stefan Wolfl |
E-mail(s) |
wolfl@uni-hd.de
|
Organization name |
Heidelberg University, Heidelberg, Germany
|
Department |
Institute of Pharmacy and Molecular Biotechnology
|
Lab |
Pharm. Biology and Bioanalytics
|
Street address |
Im Neuenheimer Feld 364
|
City |
Heidelberg |
ZIP/Postal code |
D-69120 |
Country |
Germany |
|
|
Platforms (1) |
GPL10558 |
Illumina HumanHT-12 V4.0 expression beadchip |
|
Samples (3) |
|
Relations |
BioProject |
PRJNA1022090 |